Showing results (91-100 of 387) with videos related to
Sort By:
Pageof 39
Gut|May 14, 1999
Efficient gene delivery to the inflamed colon by local administration of recombinant adenoviruses with normal or modified fibre structureS Wirtz, P R Galle, M F NeurathZeitschrift Fur Gastroenterologie|February 1, 1996
Transcription factors of T and B lymphocytes--basic research and clinical perspectives for gastroenterologyM F Neurath, K H Meyer zum BüschenfeldeFrontiers in Medicine|August 9, 2021
Innovative Diagnostic Endoscopy in Inflammatory Bowel Diseases: From High-Definition to Molecular EndoscopyChristian Bojarski, Maximilian Waldner, Timo Rath, et al.World Journal of Gastroenterology|December 16, 2015
First case report of exacerbated ulcerative colitis after anti-interleukin-6R salvage therapyRaja Atreya, Ulrike Billmeier, Timo Rath, et al.Expert Review of Gastroenterology & Hepatology|July 20, 2019
Anti-TNF biosimilars in Crohn's Disease: a patient-centric interdisciplinary approachLaurent Peyrin-Biroulet, Silvio Danese, Fraser Cummings, et al.Frontiers in Immunology|August 23, 2018
Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel DiseasesTimo Rath, Ulrike Billmeier, Fulvia Ferrazzi, et al.Frontiers in Immunology|May 1, 2026
Case Report: Successful anti-TNF antibody therapy in steroid-dependent segmental colitis associated with diverticulosis and concomitant ulcerative colitisFotios Fousekis, Jürgen Siebler, Timo Rath, et al.Crohn'S & Colitis 360|August 11, 2020
Functional Molecular Network Analysis Enables Prediction of Response to Vedolizumab Therapy in Anti-TNF Refractory IBD PatientsMatthias Breidert, Pierre Eftekhari, François Louis, et al.European Journal of Immunology|February 1, 1997
NFE, a new transcriptional activator that facilitates p50 and c-Rel-dependent IgH 3' enhancer activityY Linderson, D Cross, M F Neurath, et al.Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|May 1, 2017
Safety and efficacy of intravenous cyclophosphamide pulse therapy in therapy refractory Crohn's disease patientsS Hirschmann, R Atreya, M Englbrecht, et al.Pageof 39